ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 708

Histological Features of Localized Scleroderma‘en Coup De Sabre‘: A Study of 16 Cases

Takashi Taniguchi, Yoshihide Asano, Zenshiro Tamaki, Kaname Akamata, Naohiko Aozasa, Shinji Noda, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Miki Sugita, Hayakazu Sumida, Yoshihiro Kuwano, Miki Miyazaki, Koichi Yanaba and Shinichi Sato, Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Scleroderma is a chronic disease of unknown etiology characterized by skin fibrosis and is divided into two clinical entities: localized scleroderma and systemic sclerosis. Localized scleroderma differs from systemic sclerosis in that it is not accompanied by Raynaud’s phenomenon, acrosclerosis, and internal organ involvement. Early lesions of localized scleroderma are histologically characterized by lymphocytic perivascular infiltration in the reticular dermis and swollen endothelial cells. However, there have been few information regarding histological features other than these findings in localized scleorderma. Since en coup de sabre (ECDS) is a certain subset of localized scleroderma with a relatively uniform clinical image, we focused on this disease subset and evaluated its histopathological features.

Methods: We retrospectively evaluated 16 patients with ECDS on the basis of clinical and histological findings. For each patient, age, disease duration, and clinicopathologic data were obtained. Skin biopsies were evaluated for the following features: epidermal atrophy, spongiosis, vacuolar degeneration of the basal cell layer, necrotic keratinocytes, thickening of dermal collagen bundles, perivascular or periappendiceal inflammatory infiltrate, vacuolar changes of follicular epithelium, and melanin incontinence.

Results: Regardless of clinical manifestations, vacuolar degeneration at the dermoepidermal junction was found in all ECDS patients. Furthermore, melanin incontinence was seen in 11 (69%) patients. Importantly, keratinocyte necroses, which are frequently accompanied with severe vacuolar degeneration, were restricted to 2 patients with early and active lesions. Vacuolar changes in hair follicular epithelium were seen in 8 (50%) patients. Regarding the histological features in the dermis, dermal fibrosis was found in all patients, but the degree of fibrosis did not correlate with disease duration. In early ECDS patients (disease duration of < 3 years), moderate to severe perivascular and/or periappendiceal lymphocytic infiltration and vacuolar changes in follicular epithelium were prominent, while epidermal atrophy was less frequently observed, compared with late ECDS patients (disease duration of ≥ 6 years). 

Conclusion: Vacuolar degeneration at the dermoepidermal junction is a common histological feature in ECDS and perivascular and/or periappendiceal lymphocytic infiltration and vacuolar degeneration of follicular epithelium are characteristic especially in early ECDS, further supporting a canonical idea that the elimination of mutated epidermal cells by immune surveillance contributes to tissue damage and resultant fibrosis in localized scleroderma.


Disclosure:

T. Taniguchi,
None;

Y. Asano,
None;

Z. Tamaki,
None;

K. Akamata,
None;

N. Aozasa,
None;

S. Noda,
None;

T. Takahashi,
None;

Y. Ichimura,
None;

T. Toyama,
None;

M. Sugita,
None;

H. Sumida,
None;

Y. Kuwano,
None;

M. Miyazaki,
None;

K. Yanaba,
None;

S. Sato,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histological-features-of-localized-sclerodermaen-coup-de-sabre-a-study-of-16-cases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology